Literature DB >> 8224625

A successful case of intraarterial prednisolone injection therapy in severe ulcerative colitis unresponsive to an intensive intravenous regimen.

N Ishii1, M Chiba, T Suzuki, M Iizuka, O Masamune, N Kubo.   

Abstract

A successful case of intraarterial prednisolone injection therapy in severe ulcerative colitis unresponsive to conventional therapy, including an intensive intravenous regimen, is presented. After the direct administration of prednisolone into the mesenteric arteries, the patient's conditions markedly improved, and he succeeded in overcoming the acute stage and entered remission. Accordingly, he safely underwent elective surgery which was finally required because of the inability to withdraw prednisolone therapy. It is well worthwhile to consider this therapy in the last resort of medical therapy for ulcerative colitis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8224625     DOI: 10.1007/bf02806355

Source DB:  PubMed          Journal:  Gastroenterol Jpn        ISSN: 0435-1339


  2 in total

1.  Intraarterial prednisolone infusion therapy in ulcerative colitis.

Authors:  S Momoshima; E Kohda; K Hiramatsu; H Asakura
Journal:  AJR Am J Roentgenol       Date:  1985-11       Impact factor: 3.959

2.  Further experience in the treatment of severe attacks of ulcerative colitis.

Authors:  S C Truelove; C P Willoughby; E G Lee; M G Kettlewell
Journal:  Lancet       Date:  1978-11-18       Impact factor: 79.321

  2 in total
  2 in total

1.  Intramesenteric steroid treatment for steroid- refractory gastrointestinal graft versus host disease.

Authors:  Aynur Uğur Bilgin; Pervin Topcuoğlu; Tanzer Sancak; Nahide Konuk; Mutlu Arat
Journal:  Turk J Haematol       Date:  2012-12-05       Impact factor: 1.831

2.  Nanogels of a Succinylated Glycol Chitosan-Succinyl Prednisolone Conjugate: Release Behavior, Gastrointestinal Distribution, and Systemic Absorption.

Authors:  Haiyan Zhou; Yuri Ikeuchi-Takahashi; Yoshiyuki Hattori; Hiraku Onishi
Journal:  Int J Mol Sci       Date:  2020-03-30       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.